Stendhal is a specialty pharmaceutical company providing some of the leading branded drugs for a wide range of serious diseases that affect human health.
Strategic partnerships are the core of Stendhal’s commercial success. We have strong, long-term relationships with some of the leading global companies in the markets we serve. As their trusted partner in Latin America, we strive to bring innovative therapeutics to the patients we serve. We are interested in adding select new partners to expand our portfolio in our core therapeutic areas.
Stendhal has expertise in regulatory, pricing and market access, clinical development and sales and marketing in each of the countries and therapeutic areas in which we operate.
Currently, we operate in 14 Latin American countries delivering some of the strongest global brands to a population of over 300 million. We have a vision to expand our geographic focus in Latin America and become the leading branded specialty pharmaceutical company in Latin America.